Hit-to-lead medicinal chemistry efforts are described starting from a screening hit 1, leading to a new class of aryl sulfonamide-based MR antagonist, exemplified by 17, that possesses favourable MR binding affinity, selectivity profile against closely related NHRs, physicochemical properties and metabolic stability.
Keywords: Aryl sulfonamide; Mineralocorticoid receptor; Nonsteroidal MR antagonist.
Copyright © 2013 Elsevier Ltd. All rights reserved.